Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-07 8:06 pm Purchase | 2024-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Ikarian Capital, LLC | 970,359 10.020% | 970,359 (New Position) | Filing History |
| 2024-04-05 4:10 pm Sale | 2024-03-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 133,547 5.900% | -4,730 (-3.42%) | Filing History |
| 2024-02-14 6:00 pm Unchanged | 2023-12-31 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital, LLC | 448,101 4.600% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:57 pm Purchase | 2022-12-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 138,277 12.500% | 120,820 (+692.10%) | Filing History |
| 2023-02-14 11:26 am Sale | 2022-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital, LLC | 11,638 0.300% | -63,845 (-84.58%) | Filing History |
| 2023-02-14 11:03 am Sale | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital, LLC | 460,416 1.300% | -1,289,627 (-73.69%) | Filing History |
| 2023-02-14 11:02 am Sale | 2022-12-31 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital, LLC | 448,101 5.200% | -48,655 (-9.79%) | Filing History |
| 2022-02-14 4:43 pm Sale | 2021-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital, LLC | 75,483 8.100% | -14,221 (-15.85%) | Filing History |
| 2022-02-14 4:41 pm Sale | 2021-12-31 | 13G | ATYR PHARMA INC ATYR | Ikarian Capital, LLC | 35,048 0.100% | -853,532 (-96.06%) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital, LLC | 279,256 2.500% | -370,286 (-57.01%) | Filing History |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 134,556 13.800% | 89,488 (+198.56%) | Filing History |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital, LLC | 1,750,043 5.900% | -86,502 (-4.71%) | Filing History |
| 2022-02-14 4:36 pm Unchanged | 2021-12-31 | 13G | ODONATE, INC. ODTC | Ikarian Capital, LLC | 0 3.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:35 pm Purchase | 2021-12-31 | 13G | SCPHARMACEUTICALS INC SCPH | Ikarian Capital, LLC | 901,362 3.300% | 901,362 (New Position) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | SCIENCE 37 HLDGS INC SNCE | Ikarian Capital, LLC | 0 0.000% | -131,249 (Position Closed) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Ikarian Capital, LLC | 28 1.000% | -83 (-74.77%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital, LLC | 496,756 5.900% | -3,244 (-0.65%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital, LLC | 36,576 0.200% | -1,027,385 (-96.56%) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | MILLENDO THERAPEUTICS INC MLND | Ikarian Capital, LLC | 58,803 0.900% | -31,065 (-34.57%) | Filing History |
| 2022-02-14 4:30 pm Sale | 2021-12-31 | 13G | LYRA THERAPEUTICS INC LYRA | Ikarian Capital, LLC | 7,891 3.000% | -8,416 (-51.61%) | Filing History |